| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 6.18e-28 | 114 | 114 | 22 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 4.53e-27 | 124 | 114 | 22 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 4.68e-26 | 137 | 114 | 22 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 1.05e-22 | 192 | 114 | 22 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | PCSK5 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 AGBL5 USP17L18 USP17L17 FURIN USP17L6P USP17L3 USP12 USP17L22 CPVL USP17L15 USP17L8 USP17L13 | 3.46e-15 | 654 | 114 | 26 | GO:0008233 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 1.04e-25 | 125 | 113 | 21 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 2.39e-24 | 144 | 113 | 21 | GO:0070646 |
| GeneOntologyBiologicalProcess | post-translational protein modification | UBR1 USP17L21 USP17L4 RNF152 USP17L2 USP17L12 USP17L1 TRIM42 USP17L20 USP17L11 KLHL40 USP17L24 USP17L5 USP17L10 USP46 USP17L19 AGBL5 USP17L18 USP17L17 USP17L6P USP17L3 USP12 MED23 USP17L22 USP17L15 USP17L8 USP17L13 | 1.84e-11 | 1074 | 113 | 27 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | UBR1 USP17L21 USP17L4 RNF152 USP17L2 USP17L12 USP17L1 TRIM42 USP17L20 USP17L11 KLHL40 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 MED23 USP17L22 USP17L15 USP17L8 USP17L13 | 2.73e-11 | 1009 | 113 | 26 | GO:0070647 |
| GeneOntologyBiologicalProcess | dense core granule docking | UNC13B UNC13A | 2.98e-05 | 2 | 113 | 2 | GO:0061790 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 PANX2 ATP10A USP17L18 USP17L17 FURIN USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 9.16e-06 | 1293 | 117 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 PANX2 ATP10A USP17L18 USP17L17 FURIN USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 9.83e-06 | 1299 | 117 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 PANX2 ATP10A USP17L18 USP17L17 FURIN USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.36e-05 | 1327 | 117 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | basement membrane | FRAS1 VTN PAPLN NTN4 ENTPD1 | 6.21e-04 | 122 | 117 | 5 | GO:0005604 |
| MousePheno | increased trophectoderm apoptosis | USP17L2 USP17L15 USP17L13 | 8.48e-06 | 8 | 76 | 3 | MP:0012119 |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 3.08e-27 | 16 | 111 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 3.08e-27 | 16 | 111 | 13 | IPR006861 |
| Domain | UCH | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 6.80e-27 | 71 | 111 | 19 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 6.80e-27 | 71 | 111 | 19 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 9.19e-27 | 72 | 111 | 19 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 9.19e-27 | 72 | 111 | 19 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 9.19e-27 | 72 | 111 | 19 | IPR001394 |
| Domain | USP_CS | USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 1.10e-25 | 66 | 111 | 18 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP46 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L8 USP17L13 | 3.64e-25 | 70 | 111 | 18 | PS00972 |
| Domain | Unc-13 | UNC13B UNC13A | 1.05e-04 | 3 | 111 | 2 | IPR027080 |
| Domain | Furin_repeat | PCSK5 FRAS1 FURIN | 1.56e-04 | 18 | 111 | 3 | IPR006212 |
| Domain | FU | PCSK5 FRAS1 FURIN | 1.56e-04 | 18 | 111 | 3 | SM00261 |
| Domain | Munc13_dom-2 | UNC13B UNC13A | 3.46e-04 | 5 | 111 | 2 | IPR014772 |
| Domain | Membr_traf_MHD | UNC13B UNC13A | 3.46e-04 | 5 | 111 | 2 | PF10540 |
| Domain | MHD2 | UNC13B UNC13A | 3.46e-04 | 5 | 111 | 2 | PS51259 |
| Domain | Munc13_subgr_dom-2 | UNC13B UNC13A | 3.46e-04 | 5 | 111 | 2 | IPR019558 |
| Domain | DUF1041 | UNC13B UNC13A | 3.46e-04 | 5 | 111 | 2 | SM01145 |
| Domain | Peptidase_S8_Asp-AS | PCSK5 FURIN | 5.17e-04 | 6 | 111 | 2 | IPR023827 |
| Domain | DUF1041 | UNC13B UNC13A | 7.21e-04 | 7 | 111 | 2 | PF06292 |
| Domain | Munc13_1 | UNC13B UNC13A | 7.21e-04 | 7 | 111 | 2 | IPR014770 |
| Domain | PrprotnconvertsP | PCSK5 FURIN | 7.21e-04 | 7 | 111 | 2 | IPR002884 |
| Domain | CAPS_dom | UNC13B UNC13A | 7.21e-04 | 7 | 111 | 2 | IPR010439 |
| Domain | TLV_coat | ERVV-2 ERVV-1 | 7.21e-04 | 7 | 111 | 2 | PF00429 |
| Domain | MHD1 | UNC13B UNC13A | 7.21e-04 | 7 | 111 | 2 | PS51258 |
| Domain | P_proprotein | PCSK5 FURIN | 7.21e-04 | 7 | 111 | 2 | PF01483 |
| Domain | S8_pro-domain | PCSK5 FURIN | 7.21e-04 | 7 | 111 | 2 | IPR032815 |
| Domain | - | PCSK5 FURIN | 7.21e-04 | 7 | 111 | 2 | 3.30.70.850 |
| Domain | S8_pro-domain | PCSK5 FURIN | 7.21e-04 | 7 | 111 | 2 | PF16470 |
| Domain | AP_complex_ssu | AP2S1 AP1S2 | 7.21e-04 | 7 | 111 | 2 | IPR016635 |
| Domain | TLV/ENV_coat_polyprotein | ERVV-2 ERVV-1 | 9.57e-04 | 8 | 111 | 2 | IPR018154 |
| Domain | Peptidase_S8_His-AS | PCSK5 FURIN | 1.23e-03 | 9 | 111 | 2 | IPR022398 |
| Domain | CLAT_ADAPTOR_S | AP2S1 AP1S2 | 1.23e-03 | 9 | 111 | 2 | PS00989 |
| Domain | Peptidase_S8_Ser-AS | PCSK5 FURIN | 1.23e-03 | 9 | 111 | 2 | IPR023828 |
| Domain | VWC | FRAS1 JAG1 BMPER | 1.48e-03 | 38 | 111 | 3 | SM00214 |
| Domain | Peptidase_S8_subtilisin-rel | PCSK5 FURIN | 1.53e-03 | 10 | 111 | 2 | IPR015500 |
| Domain | SUBTILASE_ASP | PCSK5 FURIN | 1.53e-03 | 10 | 111 | 2 | PS00136 |
| Domain | SUBTILASE_HIS | PCSK5 FURIN | 1.53e-03 | 10 | 111 | 2 | PS00137 |
| Domain | SUBTILASE_SER | PCSK5 FURIN | 1.53e-03 | 10 | 111 | 2 | PS00138 |
| Domain | - | PCSK5 FURIN | 1.86e-03 | 11 | 111 | 2 | 3.40.50.200 |
| Domain | Peptidase_S8/S53_dom | PCSK5 FURIN | 1.86e-03 | 11 | 111 | 2 | IPR000209 |
| Domain | Peptidase_S8 | PCSK5 FURIN | 1.86e-03 | 11 | 111 | 2 | PF00082 |
| Domain | VWF_dom | FRAS1 JAG1 BMPER | 1.98e-03 | 42 | 111 | 3 | IPR001007 |
| Domain | Clathrin_sm-chain_CS | AP2S1 AP1S2 | 2.22e-03 | 12 | 111 | 2 | IPR000804 |
| Domain | Growth_fac_rcpt_ | PCSK5 FRAS1 NTN4 FURIN JAG1 | 2.40e-03 | 156 | 111 | 5 | IPR009030 |
| Domain | Dynein_heavy_chain_D4_dom | DNAH12 DNAH9 | 3.04e-03 | 14 | 111 | 2 | IPR024317 |
| Domain | PLAC | PCSK5 PAPLN | 3.04e-03 | 14 | 111 | 2 | PF08686 |
| Domain | Dynein_heavy_dom-2 | DNAH12 DNAH9 | 3.04e-03 | 14 | 111 | 2 | IPR013602 |
| Domain | DHC_N2 | DNAH12 DNAH9 | 3.04e-03 | 14 | 111 | 2 | PF08393 |
| Domain | AAA_8 | DNAH12 DNAH9 | 3.04e-03 | 14 | 111 | 2 | PF12780 |
| Domain | ATPase_dyneun-rel_AAA | DNAH12 DNAH9 | 3.04e-03 | 14 | 111 | 2 | IPR011704 |
| Domain | AAA_5 | DNAH12 DNAH9 | 3.04e-03 | 14 | 111 | 2 | PF07728 |
| Domain | DHC_fam | DNAH12 DNAH9 | 3.49e-03 | 15 | 111 | 2 | IPR026983 |
| Domain | Dynein_heavy_dom | DNAH12 DNAH9 | 3.49e-03 | 15 | 111 | 2 | IPR004273 |
| Domain | Dynein_heavy | DNAH12 DNAH9 | 3.49e-03 | 15 | 111 | 2 | PF03028 |
| Domain | AP_mu_sigma_su | AP2S1 AP1S2 | 3.98e-03 | 16 | 111 | 2 | IPR022775 |
| Domain | Clat_adaptor_s | AP2S1 AP1S2 | 3.98e-03 | 16 | 111 | 2 | PF01217 |
| Domain | Propept_inh | PCSK5 FURIN | 4.49e-03 | 17 | 111 | 2 | IPR009020 |
| Domain | VWC_out | FRAS1 JAG1 | 5.60e-03 | 19 | 111 | 2 | SM00215 |
| Domain | PLAC | PCSK5 PAPLN | 5.60e-03 | 19 | 111 | 2 | PS50900 |
| Domain | PLAC | PCSK5 PAPLN | 5.60e-03 | 19 | 111 | 2 | IPR010909 |
| Domain | GPCR_Rhodpsn_7TM | OR8J3 UTS2R GPR21 OR13C8 GPR52 OR8J1 APLNR MTNR1B OR4C46 OR4C13 | 6.59e-03 | 670 | 111 | 10 | IPR017452 |
| Domain | C1 | UNC13B KMT2C UNC13A | 6.83e-03 | 65 | 111 | 3 | SM00109 |
| Domain | 7tm_1 | OR8J3 UTS2R GPR21 OR13C8 GPR52 OR8J1 APLNR MTNR1B OR4C46 OR4C13 | 7.07e-03 | 677 | 111 | 10 | PF00001 |
| Domain | PE/DAG-bd | UNC13B KMT2C UNC13A | 7.12e-03 | 66 | 111 | 3 | IPR002219 |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.64e-29 | 45 | 90 | 18 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 8.06e-18 | 191 | 90 | 19 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 1.27e-16 | 221 | 90 | 19 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 2.99e-15 | 262 | 90 | 19 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 3.35e-14 | 299 | 90 | 19 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 CSF2RB USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.02e-13 | 318 | 90 | 19 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 RNF152 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 MDGA2 USP17L10 USP17L19 AGBL5 USP17L18 USP17L17 FURIN TEX101 USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 1.17e-05 | 1475 | 90 | 24 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 RNF152 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 FURIN TEX101 USP17L6P USP17L3 USP12 USP17L22 USP17L15 USP17L8 USP17L13 | 4.54e-05 | 1389 | 90 | 22 | MM15307 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-42 | 21 | 119 | 18 | 8622927 |
| Pubmed | DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-42 | 21 | 119 | 18 | 14583620 |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-42 | 21 | 119 | 18 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-42 | 21 | 119 | 18 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-42 | 21 | 119 | 18 | 12447969 |
| Pubmed | DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-42 | 21 | 119 | 18 | 18980247 |
| Pubmed | JAK2 is required for induction of the murine DUB-1 gene. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.75e-42 | 22 | 119 | 18 | 9154835 |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.42e-40 | 24 | 119 | 18 | 8995226 |
| Pubmed | Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.05e-40 | 25 | 119 | 18 | 21115691 |
| Pubmed | Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.64e-39 | 26 | 119 | 18 | 35816173 |
| Pubmed | Cdc25A and Dub3 in a high-stakes balancing act. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.45e-39 | 33 | 119 | 19 | 20228807 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 20403174 |
| Pubmed | Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 17109758 |
| Pubmed | The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 20388806 |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 19188362 |
| Pubmed | Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 11941478 |
| Pubmed | The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 10936051 |
| Pubmed | The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.55e-39 | 34 | 119 | 19 | 21448158 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.21e-38 | 35 | 119 | 19 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.21e-38 | 35 | 119 | 19 | 21239494 |
| Pubmed | The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.56e-38 | 36 | 119 | 19 | 20147298 |
| Pubmed | Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.60e-38 | 29 | 119 | 18 | 32527007 |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.24e-38 | 37 | 119 | 19 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.77e-32 | 50 | 119 | 18 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 5.46e-16 | 10 | 119 | 7 | 24207026 |
| Pubmed | USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 LCA5L ZNF521 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 AP1S2 USP17L22 CPVL USP17L15 USP17L8 USP17L13 | 1.33e-15 | 674 | 119 | 22 | 37196079 |
| Pubmed | Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells. | USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 3.58e-15 | 12 | 119 | 7 | 24695638 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 1.54e-14 | 14 | 119 | 7 | 11793228 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 2.24e-13 | 19 | 119 | 7 | 28067227 |
| Pubmed | Human and mouse proteases: a comparative genomic approach. | USP17L4 USP17L2 USP17L1 USP46 USP17L6P USP17L3 USP12 USP17L15 USP17L8 | 1.00e-11 | 81 | 119 | 9 | 12838346 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 NTN4 USP17L17 | 8.46e-09 | 119 | 119 | 8 | 28625976 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | USP17L2 USP17L15 USP17L13 | 1.56e-07 | 4 | 119 | 3 | 22984479 |
| Pubmed | Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 12070347 |
| Pubmed | Regulation of insulin exocytosis by Munc13-1. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 12871971 |
| Pubmed | Formation of perineuronal nets in organotypic mouse brain slice cultures is independent of neuronal glutamatergic activity. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 17561838 |
| Pubmed | Munc13 genotype regulates secretory amyloid precursor protein processing via postsynaptic glutamate receptors. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 23070049 |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 28489077 |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 10440375 |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 22066784 |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 32187536 |
| Pubmed | In Vivo Analysis of the Contribution of Proprotein Convertases to the Processing of FGF23. | PCSK5 FURIN | 1.16e-05 | 2 | 119 | 2 | 34149625 |
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 28772123 |
| Pubmed | Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution. | ERVV-2 ERVV-1 | 1.16e-05 | 2 | 119 | 2 | 18826608 |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 17267576 |
| Pubmed | Role of mammalian homologue of Caenorhabditis elegans unc-13-1 (Munc13-1) in the recruitment of newcomer insulin granules in both first and second phases of glucose-stimulated insulin secretion in mouse islets. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 22814762 |
| Pubmed | Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. | PCSK5 FURIN | 1.16e-05 | 2 | 119 | 2 | 10888676 |
| Pubmed | Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a novel type 2 diabetes susceptibility gene in African Americans. | CMIP MTNR1B | 1.16e-05 | 2 | 119 | 2 | 29691896 |
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 28426965 |
| Pubmed | A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 35613050 |
| Pubmed | Dynamic control of synaptic vesicle replenishment and short-term plasticity by Ca(2+)-calmodulin-Munc13-1 signaling. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 23770256 |
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 30816091 |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 19558619 |
| Pubmed | Phorbol esters modulate spontaneous and Ca2+-evoked transmitter release via acting on both Munc13 and protein kinase C. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 18701688 |
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 31851910 |
| Pubmed | The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. | USP46 USP12 | 1.16e-05 | 2 | 119 | 2 | 25855980 |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 11832228 |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 23229896 |
| Pubmed | Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs. | UNC13B UNC13A | 1.16e-05 | 2 | 119 | 2 | 11792326 |
| Pubmed | Differential evolutionary fate of an ancestral primate endogenous retrovirus envelope gene, the EnvV syncytin, captured for a function in placentation. | ERVV-2 ERVV-1 | 1.16e-05 | 2 | 119 | 2 | 23555306 |
| Pubmed | DNA sequence and analysis of human chromosome 8. | USP17L4 USP17L1 USP17L3 USP17L8 | 2.26e-05 | 48 | 119 | 4 | 16421571 |
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | UNC13B UNC13A | 3.47e-05 | 3 | 119 | 2 | 37343100 |
| Pubmed | In vivo evidence that furin from hepatocytes inactivates PCSK9. | PCSK5 FURIN | 3.47e-05 | 3 | 119 | 2 | 21147780 |
| Pubmed | The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications. | PCSK5 FURIN | 3.47e-05 | 3 | 119 | 2 | 16912035 |
| Pubmed | The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse. | UNC13B UNC13A | 3.47e-05 | 3 | 119 | 2 | 23658173 |
| Pubmed | Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. | PCSK5 FURIN | 3.47e-05 | 3 | 119 | 2 | 8670066 |
| Pubmed | Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells. | UNC13B UNC13A | 3.47e-05 | 3 | 119 | 2 | 17639022 |
| Pubmed | Thrombin activation of protein C requires prior processing by a liver proprotein convertase. | PCSK5 FURIN | 3.47e-05 | 3 | 119 | 2 | 28468828 |
| Pubmed | Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains. | PCSK5 FURIN | 3.47e-05 | 3 | 119 | 2 | 11723118 |
| Pubmed | Heterogeneous Presynaptic Distribution of Munc13 Isoforms at Retinal Synapses and Identification of an Unconventional Bipolar Cell Type with Dual Expression of Munc13 Isoforms: A Study Using Munc13-EXFP Knock-in Mice. | UNC13B UNC13A | 3.47e-05 | 3 | 119 | 2 | 33105896 |
| Pubmed | Nonconserved Ca(2+)/calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity. | UNC13B UNC13A | 3.47e-05 | 3 | 119 | 2 | 22966208 |
| Pubmed | Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. | UNC13B UNC13A | 3.47e-05 | 3 | 119 | 2 | 15988013 |
| Pubmed | Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1. | ZEB1 JAG1 | 3.47e-05 | 3 | 119 | 2 | 33046710 |
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | UNC13B UNC13A | 6.93e-05 | 4 | 119 | 2 | 10488064 |
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 16829522 |
| Pubmed | Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 8615794 |
| Pubmed | Proprotein convertases play an important role in regulating PKGI endoproteolytic cleavage and nuclear transport. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 23686857 |
| Pubmed | Neurotrophin secretion: current facts and future prospects. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 12787574 |
| Pubmed | A conserved two-step binding for the UAF1 regulator to the USP12 deubiquitinating enzyme. | USP46 USP12 | 6.93e-05 | 4 | 119 | 2 | 27650958 |
| Pubmed | WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc. | USP46 USP12 | 6.93e-05 | 4 | 119 | 2 | 39432777 |
| Pubmed | AP17 and AP19, the mammalian small chains of the clathrin-associated protein complexes show homology to Yap17p, their putative homolog in yeast. | AP2S1 AP1S2 | 6.93e-05 | 4 | 119 | 2 | 2040623 |
| Pubmed | The dystrophia myotonica WD repeat-containing protein DMWD and WDR20 differentially regulate USP12 deubiquitinase. | USP46 USP12 | 6.93e-05 | 4 | 119 | 2 | 33844468 |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | UNC13B UNC13A | 6.93e-05 | 4 | 119 | 2 | 19996097 |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | UNC13B UNC13A | 6.93e-05 | 4 | 119 | 2 | 15123597 |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | UNC13B UNC13A | 6.93e-05 | 4 | 119 | 2 | 28264913 |
| Pubmed | Proprotein convertase furin regulates osteocalcin and bone endocrine function. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 28972540 |
| Pubmed | The proprotein convertases furin and PACE4 play a significant role in tumor progression. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 10900462 |
| Pubmed | Dual mechanisms for the fibrate-mediated repression of proprotein convertase subtilisin/kexin type 9. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 18245819 |
| Pubmed | E1-mediated recruitment of a UAF1-USP deubiquitinase complex facilitates human papillomavirus DNA replication. | USP46 USP12 | 6.93e-05 | 4 | 119 | 2 | 24850727 |
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 9521771 |
| Pubmed | Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. | PCSK5 FURIN | 6.93e-05 | 4 | 119 | 2 | 15911696 |
| Pubmed | WDR20 regulates shuttling of the USP12 deubiquitinase complex between the plasma membrane, cytoplasm and nucleus. | USP46 USP12 | 6.93e-05 | 4 | 119 | 2 | 30466959 |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | UNC13B UNC13A | 1.15e-04 | 5 | 119 | 2 | 34706221 |
| Pubmed | UAF1 is a subunit of multiple deubiquitinating enzyme complexes. | USP46 USP12 | 1.15e-04 | 5 | 119 | 2 | 19075014 |
| Pubmed | WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme complex. | USP46 USP12 | 1.15e-04 | 5 | 119 | 2 | 20147737 |
| Pubmed | A Trio of Active Zone Proteins Comprised of RIM-BPs, RIMs, and Munc13s Governs Neurotransmitter Release. | UNC13B UNC13A | 1.15e-04 | 5 | 119 | 2 | 32755572 |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.01e-24 | 79 | 119 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.04e-17 | 222 | 119 | 15 | chr4p16 |
| Cytoband | 8p23.1 | USP17L4 USP17L2 USP17L1 USP17L3 USP17L8 | 5.34e-05 | 154 | 119 | 5 | 8p23.1 |
| Cytoband | 18q11.2 | TMEM241 ABHD3 ZNF521 | 2.53e-04 | 47 | 119 | 3 | 18q11.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | USP17L4 USP17L2 USP17L1 USP17L3 USP17L8 | 3.75e-04 | 234 | 119 | 5 | chr8p23 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q11 | TMEM241 ABHD3 ZNF521 | 1.44e-03 | 85 | 119 | 3 | chr18q11 |
| Cytoband | 3p14.3 | DNAH12 ARHGEF3 | 2.76e-03 | 30 | 119 | 2 | 3p14.3 |
| GeneFamily | UNC13 homologs | UNC13B UNC13A | 1.04e-04 | 4 | 76 | 2 | 836 |
| GeneFamily | Proprotein convertase subtilisin/kexin family | PCSK5 FURIN | 6.16e-04 | 9 | 76 | 2 | 973 |
| GeneFamily | Olfactory receptors, family 8 | OR8J2 OR8J3 OR8J1 | 1.14e-03 | 49 | 76 | 3 | 155 |
| GeneFamily | Ubiquitin specific peptidases | USP17L2 USP46 USP12 | 1.69e-03 | 56 | 76 | 3 | 366 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZEB1 TSHZ1 | 1.77e-03 | 15 | 76 | 2 | 529 |
| GeneFamily | Dyneins, axonemal | DNAH12 DNAH9 | 2.28e-03 | 17 | 76 | 2 | 536 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZEB1 ZNF560 ZNF813 ZNF521 ZNF519 ZNF441 ZFX RLF TSHZ1 | 3.09e-03 | 718 | 76 | 9 | 28 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 9.11e-26 | 86 | 114 | 18 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.55e-23 | 112 | 114 | 18 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 FHL2 USP17L22 USP17L15 USP17L8 USP17L13 | 3.48e-22 | 160 | 114 | 19 | MM1155 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | UBR1 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 HSPBAP1 USP17L11 USP17L5 USP17L10 USP17L19 ITGAL USP17L18 SLC26A8 LRP10 USP17L17 USP17L6P USP17L3 TSHZ1 FHL2 USP17L22 USP17L15 USP17L8 USP17L13 | 4.56e-12 | 1072 | 114 | 25 | MM1031 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 INPP5B USP17L5 USP17L10 USP17L19 USP17L18 SIDT2 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.82e-12 | 647 | 114 | 20 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | TCTN3 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 CMIP USP17L17 PPIL3 USP17L6P USP17L3 USP12 BMPER USP17L22 USP17L15 USP17L8 USP17L13 | 1.66e-09 | 1198 | 114 | 23 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 INPP5B USP17L5 USP17L10 USP17L19 USP17L18 SIDT2 USP17L17 USP17L6P USP17L3 FHL2 USP17L22 USP17L15 USP17L8 USP17L13 | 6.68e-08 | 1226 | 114 | 21 | MM979 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | FRAS1 RNF152 GPR21 MEI1 ATP10A FHL2 | 5.54e-06 | 179 | 110 | 6 | 820289f14ecf165758529c236bb220bb1a744f02 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | FRAS1 RNF152 GPR21 MEI1 ATP10A FHL2 | 5.54e-06 | 179 | 110 | 6 | e5f781d35449628a7f356d71e26231dd63482eec |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | TMEM241 CRACR2A MEI1 FANCA ENTPD1 MED23 | 5.72e-06 | 180 | 110 | 6 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | TMEM241 CRACR2A FANCA TBC1D4 ENTPD1 MED23 | 6.29e-06 | 183 | 110 | 6 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PCSK5 RNF152 NTN4 ENTPD1 TSHZ1 FHL2 | 9.04e-06 | 195 | 110 | 6 | b0d408f8bc1701a87596ed55efcd90749fee33e6 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PCSK5 RNF152 NTN4 ENTPD1 TSHZ1 FHL2 | 9.04e-06 | 195 | 110 | 6 | a486a7acea0e91048cc48afa0dbd3926d30bc217 |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | ATP10A TBC1D4 CSF2RB ENTPD1 APLNR CPVL | 9.58e-06 | 197 | 110 | 6 | 143607d195c8aa2b94d995af0b2ef38582565611 |
| ToppCell | Bronchial_Biopsy-Endothelial-Endothelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | ZEB1 ZNF521 CSF2RB ENTPD1 APLNR AP1S2 | 9.86e-06 | 198 | 110 | 6 | d4a4e5c358d26d09ff27541ce49d0db75c1cd08e |
| ToppCell | Bronchial_Biopsy-Endothelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | ZEB1 ZNF521 CSF2RB ENTPD1 APLNR AP1S2 | 9.86e-06 | 198 | 110 | 6 | ec80b05b8a1800c341b5741bf3e57213308398a7 |
| Drug | CV-1 | PCSK5 FANCA AP2S1 FURIN SCNN1B BMPER CPVL THAP12 | 3.93e-06 | 213 | 98 | 8 | CID000130105 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 9.31e-35 | 46 | 113 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 KMT2C USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.74e-33 | 69 | 113 | 20 | DOID:1682 (implicated_via_orthology) |
| Disease | cold shock domain-containing protein E1 measurement | VTN ARHGEF3 | 4.35e-05 | 3 | 113 | 2 | EFO_0802416 |
| Disease | intersectin-1 measurement | VTN ARHGEF3 | 4.35e-05 | 3 | 113 | 2 | EFO_0801733 |
| Disease | calcium-binding and coiled-coil domain-containing protein 2 measurement | VTN ARHGEF3 | 8.68e-05 | 4 | 113 | 2 | EFO_0802356 |
| Disease | MAGUK p55 subfamily member 7 measurement | VTN ARHGEF3 | 8.68e-05 | 4 | 113 | 2 | EFO_0802724 |
| Disease | lysozyme-like protein 2 measurement | VTN ARHGEF3 | 1.44e-04 | 5 | 113 | 2 | EFO_0801779 |
| Disease | n-acetylserotonin O-methyltransferase-like protein measurement | VTN ARHGEF3 | 2.16e-04 | 6 | 113 | 2 | EFO_0801818 |
| Disease | thioredoxin domain-containing protein 5 measurement | UTS2R ARHGEF3 | 2.16e-04 | 6 | 113 | 2 | EFO_0802128 |
| Disease | ribonucleoside-diphosphate reductase subunit M2 B measurement | VTN ARHGEF3 | 3.01e-04 | 7 | 113 | 2 | EFO_0802022 |
| Disease | dynein light chain roadblock-type 1 measurement | VTN ARHGEF3 | 4.01e-04 | 8 | 113 | 2 | EFO_0008114 |
| Disease | CXCL1 measurement | VTN CRACR2A | 5.14e-04 | 9 | 113 | 2 | EFO_0010777 |
| Disease | non-receptor tyrosine-protein kinase TYK2 measurement | VTN ARHGEF3 | 6.41e-04 | 10 | 113 | 2 | EFO_0008251 |
| Disease | f-box/LRR-repeat protein 4 measurement | PCIF1 ARHGEF3 | 6.41e-04 | 10 | 113 | 2 | EFO_0802538 |
| Disease | renal fibrosis (implicated_via_orthology) | GPR21 GPR52 | 1.90e-03 | 17 | 113 | 2 | DOID:0050855 (implicated_via_orthology) |
| Disease | urate measurement, bone density | FRAS1 PLB1 CRACR2A FANCA RANBP17 SLC26A8 CSF2RB DNAH9 | 2.67e-03 | 619 | 113 | 8 | EFO_0003923, EFO_0004531 |